{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:23:11Z","timestamp":1772799791452,"version":"3.50.1"},"reference-count":158,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02720","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T05:33:05Z","timestamp":1543210385000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications"],"prefix":"10.3389","volume":"9","author":[{"given":"Muhammad","family":"Haseeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ayaz","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangdun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"B1","first-page":"1975","volume-title":"SEER Cancer Statistics Review","author":"Howlader","year":"2016"},{"key":"B2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/sj.leu.2402363","article-title":"Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities","volume":"16","author":"Hulkkonen","year":"2002","journal-title":"Leukemia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jaci.2013.01.046","article-title":"B-cell biology and development","volume":"131","author":"Pieper","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.3488","article-title":"DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia","volume":"48","author":"Oakes","year":"2016","journal-title":"Nat Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/eji.200636452","article-title":"Antigen presentation and transfer between B cells and macrophages","volume":"37","author":"Harvey","year":"2007","journal-title":"Eur J Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","article-title":"B cell receptor signaling in chronic lymphocytic leukemia","volume":"34","author":"Burger","year":"2013","journal-title":"Trends Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"Duhren-von Minden","year":"2012","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.8266078","article-title":"Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor","volume":"262","author":"Russell","year":"1993","journal-title":"Science"},{"key":"B13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V94.2.748","article-title":"Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia","volume":"94","author":"Schaffner","year":"1999","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0140-673610117-4","article-title":"Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia","volume":"353","author":"Stankovic","year":"1999","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V88.4.1177.bloodjournal8841177","article-title":"Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization","volume":"88","author":"Vaandrager","year":"1996","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Camacho","year":"2002","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood-2002-05-1592","article-title":"Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma","volume":"101","author":"Wlodarska","year":"2003","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.191.2.395","article-title":"Clonal deleterious mutations in the I\u03baB\u03b1 gene in the malignant cells in Hodgkin's lymphoma","volume":"191","author":"Jungnickel","year":"2000","journal-title":"J Exp Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/path.1454","article-title":"Inactivating I kappa B epsilon mutations in Hodgkin\/Reed-Sternberg cells","volume":"201","author":"Emmerich","year":"2003","journal-title":"J Pathol."},{"key":"B20","first-page":"5640","article-title":"Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells","volume":"60","author":"Muschen","year":"2000","journal-title":"Cancer Res."},{"key":"B21","first-page":"5640","article-title":"High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies","volume":"58","author":"Avet-Loiseau","year":"1998","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat Genet."},{"key":"B23","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood.V91.12.4457","article-title":"Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma","volume":"91","author":"Chesi","year":"1998","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1182\/blood.V90.11.4266","article-title":"Mutations in the Fas antigen in patients with multiple myeloma","volume":"90","author":"Landowski","year":"1997","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1182\/blood.V88.11.4110.4110","article-title":"The t(9; 14)(p13; q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene","volume":"88","author":"Iida","year":"1996","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"key":"B27","first-page":"2732","article-title":"Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma","volume":"53","author":"Ye","year":"1993","journal-title":"Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM198711053171904","article-title":"Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas","volume":"317","author":"Weiss","year":"1987","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1182\/blood.V77.5.1057.1057","article-title":"MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas","volume":"77","author":"Ladanyi","year":"1991","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V92.9.3018","article-title":"Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity","volume":"92","author":"Gronbaek","year":"1998","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2002-02-0382","article-title":"ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma","volume":"100","author":"Gronbaek","year":"2002","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","article-title":"Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients With B-Cell non-Hodgkin9s lymphoma","volume":"90","author":"Koduru","year":"1997","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.leu.2401315","article-title":"Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma","volume":"13","author":"Moller","year":"1999","journal-title":"Leukemia"},{"key":"B34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1126\/science.6401867","article-title":"Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas","volume":"219","author":"Dalla-Favera","year":"1983","journal-title":"Science"},{"key":"B35","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","article-title":"Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells","volume":"79","author":"Taub","year":"1982","journal-title":"Proc Nat Acad Sci USA."},{"key":"B36","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","article-title":"p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia","volume":"88","author":"Gaidano","year":"1991","journal-title":"Proc Natl Acad Sci USA."},{"key":"B37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0002-9440(10)64941-3","article-title":"Genetic alterations of the retinoblastoma-related gene RB2\/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes","volume":"156","author":"Cinti","year":"2000","journal-title":"Am J Pathol."},{"key":"B38","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","article-title":"The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas","volume":"93","author":"Dierlamm","year":"1999","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","article-title":"Bcl10 is involved in t (1; 14)(p22; q32) of MALT B cell lymphoma and mutated in multiple tumor types","volume":"96","author":"Willis","year":"1999","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/8767","article-title":"Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)","volume":"22","author":"Zhang","year":"1999","journal-title":"Nat Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1182\/blood-2013-07-515361","article-title":"Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)","volume":"123","author":"Woyach","year":"2014","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3324\/haematol.2016.151100","article-title":"T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers","volume":"102","author":"Palma","year":"2017","journal-title":"Haematologica"},{"key":"B45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1182\/blood-2015-11-682377","article-title":"Extracellular vesicles released by CD40\/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells","volume":"128","author":"Smallwood","year":"2016","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/leu.2017.11","article-title":"Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood","volume":"31","author":"Herndon","year":"2017","journal-title":"Leukemia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1158\/0008-5472.CAN-12-2749","article-title":"CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility","volume":"73","author":"Girbl","year":"2013","journal-title":"Cancer Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"40558","DOI":"10.18632\/oncotarget.9941","article-title":"Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"B49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1182\/blood-2015-02-626754","article-title":"Mechanisms of PD-L1\/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Emicro-TCL1 CLL mouse model","volume":"126","author":"McClanahan","year":"2015","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.celrep.2016.02.084","article-title":"Human cytotoxic T lymphocytes form dysfunctional immune synapses with B cells characterized by non-polarized lytic granule release","volume":"15","author":"Kabanova","year":"2016","journal-title":"Cell Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.4049\/jimmunol.1403165","article-title":"Usp9X is required for lymphocyte activation and homeostasis through its control of ZAP70 ubiquitination and PKCbeta kinase activity","volume":"196","author":"Naik","year":"2016","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12967-016-0865-1","article-title":"GIFT4 fusokine converts leukemic B cells into immune helper cells","volume":"14","author":"Deng","year":"2016","journal-title":"J Transl Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/leu.2016.362","article-title":"Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements","volume":"31","author":"Vardi","year":"2017","journal-title":"Leukemia"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s13277-013-0832-x","article-title":"Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions","volume":"34","author":"Jadidi-Niaragh","year":"2013","journal-title":"Tumor Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1182\/blood-2013-12-546416","article-title":"CLL-cells induce IDOhi CD14+ HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs","volume":"124","author":"Jitschin","year":"2014","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e78091","DOI":"10.1371\/journal.pone.0078091","article-title":"Th17\/IL-17A might play a protective role in chronic lymphocytic leukemia immunity","volume":"8","author":"Hus","year":"2013","journal-title":"PLoS ONE"},{"key":"B57","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1365-2141.2009.08014.x","article-title":"Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells","volume":"148","author":"Idler","year":"2010","journal-title":"Br J Haematol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3109\/10428194.2014.986479","article-title":"Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias","volume":"56","author":"Lad","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1679\/aohc.73.1","article-title":"The microstructure of secondary lymphoid organs that support immune cell trafficking","volume":"73","author":"Matsuno","year":"2010","journal-title":"Arch Histol Cytol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1128\/MCB.01369-13","article-title":"Control of dendritic cell migration, T cell-dependent immunity, and autoimmunity by protein tyrosine phosphatase PTPN12 expressed in dendritic cells","volume":"34","author":"Rhee","year":"2014","journal-title":"Mol Cell Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/imr.12223","article-title":"Macrophage heterogeneity in tissues: phenotypic diversity and functions","volume":"262","author":"Gordon","year":"2014","journal-title":"Immunol Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4049\/jimmunol.175.1.342","article-title":"Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences","volume":"175","author":"Stout","year":"2005","journal-title":"J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbcan.2015.06.009","article-title":"Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment","volume":"1865","author":"Lahmar","year":"2016","journal-title":"BBA Rev Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.gdata.2015.11.010","article-title":"Transcriptomic analysis of monocytes and macrophages derived from CLL patients which display differing abilities to respond to therapeutic antibody immune complexes","volume":"7","author":"Burgess","year":"2016","journal-title":"Genom Data"},{"key":"B66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bcmd.2012.12.003","article-title":"Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?","volume":"50","author":"Filip","year":"2013","journal-title":"Blood Cells Mol Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1038\/srep12524","article-title":"Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression","volume":"177","author":"Martinez","year":"2006","journal-title":"J Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","article-title":"Distinctive features of \u201cnurselike\u201d cells that differentiate in the context of chronic lymphocytic leukemia","volume":"99","author":"Tsukada","year":"2002","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","article-title":"Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia","volume":"110","author":"B\u00fcrkle","year":"2007","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1182\/blood-2004-03-0889","article-title":"Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha","volume":"106","author":"Nishio","year":"2005","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1182\/blood-2004-10-3873","article-title":"CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival","volume":"105","author":"Deaglio","year":"2005","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/leu.2012.165","article-title":"Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function","volume":"27","author":"DiLillo","year":"2013","journal-title":"Leukemia"},{"key":"B74","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1182\/blood.V87.10.4382.bloodjournal87104382","article-title":"Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion","volume":"87","author":"di Celle","year":"1996","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.3109\/10428194.2012.672735","article-title":"CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro","volume":"53","author":"Burgess","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1182\/blood-2004-12-4918","article-title":"Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells","volume":"106","author":"Burger","year":"2005","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1182\/blood-2013-02-484386","article-title":"Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia","volume":"122","author":"Yaktapour","year":"2013","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1038\/sj.onc.1210519","article-title":"Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a","volume":"26","author":"Ticchioni","year":"2007","journal-title":"Oncogene"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1182\/blood-2014-11-610329","article-title":"The PI3K\/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Emicro-TCL1 mouse model","volume":"125","author":"Blunt","year":"2015","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","article-title":"Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis","volume":"15","author":"Georgoudaki","year":"2016","journal-title":"Cell Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20554","article-title":"Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells","volume":"539","author":"De Henau","year":"2016","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","article-title":"PI3K\u03b3 is a molecular switch that controls immune suppression","volume":"539","author":"Kaneda","year":"2016","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1046\/j.1365-2141.2001.03117.x","article-title":"Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern","volume":"115","author":"Rezvany","year":"2001","journal-title":"Br J Haematol."},{"key":"B84","first-page":"4497","article-title":"The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response","volume":"63","author":"Orsini","year":"2003","journal-title":"Cancer Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"46301","DOI":"10.18632\/oncotarget.10093","article-title":"Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia","volume":"7","author":"Toniolo","year":"2016","journal-title":"Oncotarget"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1158\/2159-8290.CD-14-0096","article-title":"Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation","volume":"4","author":"Heinig","year":"2014","journal-title":"Cancer Discov."},{"key":"B87","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/ejh.13065","article-title":"Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients","volume":"101","author":"Palma","year":"2018","journal-title":"Eur J Haematol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/sji.12172","article-title":"High functional CD70 expression on alpha-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia","volume":"79","author":"Junevik","year":"2014","journal-title":"Scand J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-4614-8051-8_10","article-title":"Critical signal transduction pathways in CLL","volume":"792","author":"Ghosh","year":"2013","journal-title":"Adv Exp Med Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.hoc.2013.01.002","article-title":"Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications","volume":"27","author":"Herishanu","year":"2013","journal-title":"Hematol Oncol Clin North Am."},{"key":"B91","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","article-title":"The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells","volume":"111","author":"Longo","year":"2008","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bjh.12564","article-title":"Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis","volume":"164","author":"Ding","year":"2014","journal-title":"Br J Haematol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"756\u201364","DOI":"10.1016\/j.exphem.2010.05.003","article-title":"Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia","volume":"38","author":"Cuesta-Mateos","year":"2010","journal-title":"Exp Hematol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1182\/blood-2011-07-370403","article-title":"Surface IgM stimulation induces MEK1\/2-dependent MYC expression in chronic lymphocytic leukemia cells","volume":"119","author":"Krysov","year":"2012","journal-title":"Blood"},{"key":"B96","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1349-7006.2011.02046.x","article-title":"Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"102","author":"Igawa","year":"2011","journal-title":"Cancer Sci."},{"key":"B98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1084\/jem.184.2.407","article-title":"Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes","volume":"184","author":"Solvason","year":"1996","journal-title":"J Exp Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","article-title":"NF-kB in development and progression of human cancer","volume":"446","author":"Dolcet","year":"2005","journal-title":"Virchows Arch."},{"key":"B100","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ijc.28974","article-title":"Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6","volume":"136","author":"Bhattacharya","year":"2015","journal-title":"Int J Cancer"},{"key":"B101","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1158\/0008-5472.CAN-14-2814","article-title":"Characterization of a c-Rel Inhibitor that mediates anticancer properties in hematologic malignancies by blocking NF-kappaB-controlled oxidative stress responses","volume":"76","author":"Shono","year":"2016","journal-title":"Cancer Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"J Exp Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood-2008-02-139725","article-title":"Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells","volume":"113","author":"Rosati","year":"2009","journal-title":"Blood"},{"key":"B104","doi-asserted-by":"publisher","first-page":"16559","DOI":"10.18632\/oncotarget.4116","article-title":"Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL","volume":"6","author":"De Falco","year":"2015","journal-title":"Oncotarget"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.3324\/haematol.2015.138172","article-title":"Kruppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling","volume":"101","author":"Filarsky","year":"2016","journal-title":"Haematologica"},{"key":"B106","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2407-13-88","article-title":"E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors","volume":"13","author":"Jordaan","year":"2013","journal-title":"BMC Cancer"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1182\/blood-2010-02-269878","article-title":"LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis","volume":"116","author":"Gutierrez","year":"2010","journal-title":"Blood"},{"key":"B108","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2174\/156800910793605794","article-title":"Wnt\/\u03b2-catenin\/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options","volume":"10","author":"K Gandhirajan","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"B109","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.3892\/mmr.2016.5111","article-title":"Bruton's tyrosine kinase inhibitor restrains Wnt signaling in chronic lymphocytic leukemia","volume":"13","author":"Li","year":"2016","journal-title":"Mol Med Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1158\/1078-0432.CCR-15-0154","article-title":"Autocrine signaling by Wnt-5a deregulates chemotaxis of leukemic cells and predicts clinical outcome in chronic lymphocytic leukemia","volume":"22","author":"Janovska","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/labinvest.3780310","article-title":"Loss of Fas (CD95\/APO-1) regulatory function is an important step in early MALT-type lymphoma development","volume":"81","author":"Seeberger","year":"2001","journal-title":"Lab Invest."},{"key":"B112","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood.V95.11.3520","article-title":"Follicular lymphomas9 BCL-2\/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t (14; 18) translocation","volume":"95","author":"J\u00e4ger","year":"2000","journal-title":"Blood"},{"key":"B113","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc1819","article-title":"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis","volume":"6","author":"Cully","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e10859","DOI":"10.1371\/journal.pone.0010859","article-title":"miR-22 forms a regulatory loop in PTEN\/AKT pathway and modulates signaling kinetics","volume":"5","author":"Bar","year":"2010","journal-title":"PLoS ONE"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1038\/leu.2015.105","article-title":"The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K\/AKT\/S6 pathway and promotes apoptosis in CLL","volume":"29","author":"Balakrishnan","year":"2015","journal-title":"Leukemia"},{"key":"B116","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1182\/blood-2005-04-1718","article-title":"ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)","volume":"107","author":"Richardson","year":"2006","journal-title":"Blood"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","article-title":"A sustained activation of PI3K\/NF-\u03baB pathway is critical for the survival of chronic lymphocytic leukemia B cells","volume":"18","author":"Cuni","year":"2004","journal-title":"Leukemia"},{"key":"B118","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1038\/onc.2014.450","article-title":"Hedgehog\/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia","volume":"34","author":"Kern","year":"2015","journal-title":"Oncogene"},{"key":"B119","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cyto.2015.12.025","article-title":"TC-PTP and PTP1B: regulating JAK-STAT signaling, controlling lymphoid malignancies","volume":"82","author":"Pike","year":"2016","journal-title":"Cytokine"},{"key":"B120","doi-asserted-by":"publisher","first-page":"12953","DOI":"10.18632\/oncotarget.14588","article-title":"Dual SYK\/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.4049\/jimmunol.1002106","article-title":"Marginal zone B cells regulate antigen capture by marginal zone macrophages","volume":"186","author":"You","year":"2011","journal-title":"J Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/eji.201444983","article-title":"Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses","volume":"45","author":"Veninga","year":"2015","journal-title":"Eur J Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nri2454","article-title":"The who, how and where of antigen presentation to B cells","volume":"9","author":"Batista","year":"2009","journal-title":"Nature Rev Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/embor.2012.111","article-title":"Activation of B cells by non-canonical helper signals","volume":"13","author":"Cerutti","year":"2012","journal-title":"EMBO Rep."},{"key":"B125","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1182\/blood-2002-10-3123","article-title":"Macrophage- and dendritic cell\u2013dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF","volume":"101","author":"Craxton","year":"2003","journal-title":"Blood"},{"key":"B126","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","article-title":"BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator","volume":"285","author":"Moore","year":"1999","journal-title":"Science"},{"key":"B127","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/eji.1830220314","article-title":"Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10","volume":"22","author":"O'Garra","year":"1992","journal-title":"Eur J Immunol."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062805","article-title":"Cross talk between peritoneal macrophages and B-1 cells in vitro","author":"Thies","year":"2013","journal-title":"PLoS ONE"},{"key":"B129","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2567.2004.01969.x","article-title":"Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro","volume":"113","author":"Popi","year":"2004","journal-title":"Immunology"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/eji.200940288","article-title":"Macrophage polarization to a unique phenotype driven by B cells","volume":"40","author":"Wong","year":"2010","journal-title":"Eur J Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/leu.2012.63","article-title":"Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia","volume":"26","author":"Sivina","year":"2012","journal-title":"Leukemia"},{"key":"B132","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"B133","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bbamcr.2015.07.009","article-title":"Microenvironment interactions and B-cell receptor signaling in chronic lymphocytic leukemia: implications for disease pathogenesis AND treatment","volume":"1863","author":"Ten Hacken","year":"2016","journal-title":"BBA Mol Cell Res."},{"key":"B135","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.V100.5.1795.h81702001795_1795_1801","article-title":"Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1","volume":"100","author":"Pedersen","year":"2002","journal-title":"Blood"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","article-title":"Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer","volume":"120","author":"Ramsay","year":"2012","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"crossref","first-page":"46.9.","DOI":"10.4049\/jimmunol.188.Supp.46.9","article-title":"SLAMF1\/CD150 is a signaling receptor in a subset of chronic lymphocytic leukemia cells (46.9)","volume":"188","author":"Bologna","year":"2012","journal-title":"J Immunol."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185940","article-title":"The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling","author":"Gordiienko","year":"2017","journal-title":"PLoS ONE"},{"key":"B139","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/icb.2010.14","article-title":"CD150 regulates JNK1\/2 activation in normal and Hodgkin's lymphoma B cells","volume":"88","author":"Yurchenko","year":"2010","journal-title":"Immunol Cell Biol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3109\/10428194.2014.917641","article-title":"Emerging therapies for refractory chronic lymphocytic leukemia","volume":"56","author":"Kutsch","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B141","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1182\/blood-2010-02-266296","article-title":"An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue-and tumor-associated macrophages but does not inhibit inflammation","volume":"116","author":"MacDonald","year":"2010","journal-title":"Blood"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.955356","article-title":"Targeting tumor-associated macrophages in cancer therapy and understanding their complexity","author":"Cannarile","year":"2014","journal-title":"Oncoimmunology"},{"key":"B143","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-15-3099","article-title":"Colony-stimulating Factor-1 receptor is required for nurse-like cell survival in chronic lymphocytic leukemia","volume":"22","author":"Polk","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","article-title":"Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy","volume":"25","author":"Ries","year":"2014","journal-title":"Cancer Cell"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.celrep.2016.01.042","article-title":"Targeting macrophages sensitizes chronic lymphocytic leukemia to apoptosis and inhibits disease progression","volume":"14","author":"Galletti","year":"2016","journal-title":"Cell Rep."},{"key":"B146","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1158\/1078-0432.CCR-15-1304","article-title":"Interactions between ibrutinib and anti-CD20 antibodies: competing effects on the outcome of combination therapy","volume":"22","author":"Skarzynski","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B147","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell"},{"key":"B148","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/19420862.2015.1011450","article-title":"Macrophages are critical effectors of antibody therapies for cancer","volume":"7","author":"Weiskopf","year":"2015","journal-title":"MAbs"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2007.14.5367","article-title":"Lenalidomide for the treatment of B-cell malignancies","volume":"26","author":"Chanan-Khan","year":"2008","journal-title":"J Clin Oncol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1182\/blood-2012-08-447664","article-title":"Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment","volume":"121","author":"Schulz","year":"2013","journal-title":"Blood"},{"key":"B151","doi-asserted-by":"publisher","first-page":"55","DOI":"10.17219\/acem\/29264","article-title":"Cytotoxic activity of valproic Acid on primary chronic lymphocytic leukemia cells","volume":"41","author":"Karp","year":"2015","journal-title":"Cytogenetics"},{"key":"B152","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J."},{"key":"B153","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/leu.2009.176","article-title":"Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis","volume":"23","author":"Stamatopoulos","year":"2009","journal-title":"Leukemia"},{"key":"B154","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1756-8722-6-53","article-title":"Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia\/lymphoma","volume":"6","author":"Dong","year":"2013","journal-title":"J Hematol Oncol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4149\/neo_2011_01_35","article-title":"Epigenetic modulation of gene expression of human leukemia cell lines-induction of cell death and senescence","volume":"58","author":"Elknerova","year":"2011","journal-title":"Neoplasma"},{"key":"B156","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-017-0436-9","article-title":"Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment","volume":"10","author":"Yoshida","year":"2017","journal-title":"Journal of hematology & oncology"},{"key":"B157","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000430980","article-title":"Expression of programmed death 1 ligand in different compartments of chronic lymphocytic leukemia","volume":"134","author":"Grzywnowicz","year":"2015","journal-title":"Acta Haematol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1182\/blood-2015-11-679134","article-title":"Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia","volume":"127","author":"Fraietta","year":"2016","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02720\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T14:15:54Z","timestamp":1694096154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02720\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":158,"alternative-id":["10.3389\/fimmu.2018.02720"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02720","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"article-number":"2720"}}